RNS Number : 5092F Unicorn Asset Management Limited 04 March 2024 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of
RNS Number : 4140F Renalytix PLC 04 March 2024 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
RNS Number : 3507F Renalytix PLC 01 March 2024 The following amendment has been made to the ' Grant of Share Options ' announcement released on 23 November 2023 at 07:00 under RNS No 3917U . The sentence " All the Share Options granted one twelfth of the Share Options vest 3 months from the
RNS Number : 9346E Renalytix PLC 29 February 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF MAR. THE PERSON RESPONSIBLE FOR ARRANGING THE RELEASE OF THIS ANNOUNCEMENT ON BEHALF OF RENALYTIX IS JAMES MCCULLOUGH , CEO. Renalytix plc ("Renalytix" or the "Company")
RNS Number : 2070D Renalytix PLC 15 February 2024 Renalytix plc ("Renalytix" or the "Company") Half Year Report LONDON and SALT LAKE CITY , February 15, 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing
RNS Number : 6963C Renalytix PLC 09 February 2024 Renalytix plc ("Renalytix" or the "Company") Renalytix to Participate in the BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference LONDON and SALT LAKE CITY , February 9, 2024 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX)
RNS Number : 5654C Renalytix PLC 09 February 2024 Renalytix plc ("Renalytix" or the "Company") Centers for Medicare & Medicaid Services Publishes Draft Local Coverage Determination for KidneyIntelX and kidneyintelX.dkd LONDON and SALT LAKE CITY , February 9, 2024 - Renalytix plc (NASDAQ:
RNS Number : 9171Z Renalytix PLC 17 January 2024 Renalytix plc ("Renalytix" or the "Company") Update on kidneyIntelX.dkd Local Coverage Determination Consideration Local Coverage Determination would result in contracted coverage for an estimated additional five million Medicare patients
RNS Number : 1665Z Renalytix PLC 10 January 2024 Renalytix plc ("Renalytix" or the "Company") New published data for KidneyIntelX™ New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease Electronic health record deployment of
RNS Number : 0685X Renalytix PLC 18 December 2023 Renalytix plc ("Renalytix" or the "Company") Issue of Shares LONDON and SALT LAKE CITY - December 18, 2023 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) , announces the repayment of $1.06 million of the Company's convertible bond and the